Shared care protocol CV40 lanreotide (Somatuline Autogel) for acromegaly, carcinoid syndrome and other peptide hormone secreting tumours
CV40 lanreotide (Somatuline Autogel) for acromegaly, carcinoid syndrome and other peptide hormone secreting tumours.
Access to Shared care supporting documents and list of additional Shared Care Protocols
